Azure Synthetics
Premium research peptides
Research family
Incretin, energy-use, and metabolic-signaling research.
Prohibitin-targeting metabolic research peptide
Adipotide is a prohibitin-targeting peptidomimetic studied for adipose vasculature signaling in metabolic research, including preclinical and primate obesity literature.
AMPK-pathway research compound
AICAR is an AMPK-pathway research compound used as a reference in cellular energy-sensing, glucose uptake, lipid metabolism, and exercise-mimetic literature.
GH fragment 176-191 research peptide
AOD-9604 is a modified fragment of human growth hormone 176-191 studied around fat-metabolism signaling. Its market interest is high, while evidence discussions stay narrower…
GLP-1 / glucagon dual-agonist research peptide
Mazdutide sits in the GLP-1 / glucagon dual-agonist research lane, where interest centers on incretin signaling, energy expenditure, and metabolic markers.
ERR pathway metabolic research compound
SLU-PP-332 is an ERR-pathway research compound studied in exercise-mimetic and metabolic adaptation literature.
Stabilized GHRH analog research peptide
Tesamorelin is a stabilized GHRH analog with clinical literature around GH-axis signaling and visceral adipose tissue endpoints in HIV-associated lipodystrophy research.
GIP / GLP-1 dual-agonist research peptide
Tirzepatide is a dual GIP / GLP-1 receptor agonist reference point in metabolic research. It anchors comparisons across incretin signaling, glycemic markers, and body-composition…
GIP / GLP-1 / glucagon tri-agonist series
Retatrutide is a metabolic research peptide studied as a triple agonist at GIP, GLP-1, and glucagon receptors. It carries one of the strongest human-trial…